Cargando…

Profiling the Tox21 Chemical Collection for Acetylcholinesterase Inhibition

BACKGROUND: Inhibition of acetylcholinesterase (AChE), a biomarker of organophosphorous and carbamate exposure in environmental and occupational human health, has been commonly used to identify potential safety liabilities. So far, many environmental chemicals, including drug candidates, food additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuaizhang, Zhao, Jinghua, Huang, Ruili, Travers, Jameson, Klumpp-Thomas, Carleen, Yu, Wenbo, MacKerell, Alexander D., Sakamuru, Srilatha, Ooka, Masato, Xue, Fengtian, Sipes, Nisha S., Hsieh, Jui-Hua, Ryan, Kristen, Simeonov, Anton, Santillo, Michael F., Xia, Menghang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Environmental Health Perspectives 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041433/
https://www.ncbi.nlm.nih.gov/pubmed/33844597
http://dx.doi.org/10.1289/EHP6993
_version_ 1783677931228233728
author Li, Shuaizhang
Zhao, Jinghua
Huang, Ruili
Travers, Jameson
Klumpp-Thomas, Carleen
Yu, Wenbo
MacKerell, Alexander D.
Sakamuru, Srilatha
Ooka, Masato
Xue, Fengtian
Sipes, Nisha S.
Hsieh, Jui-Hua
Ryan, Kristen
Simeonov, Anton
Santillo, Michael F.
Xia, Menghang
author_facet Li, Shuaizhang
Zhao, Jinghua
Huang, Ruili
Travers, Jameson
Klumpp-Thomas, Carleen
Yu, Wenbo
MacKerell, Alexander D.
Sakamuru, Srilatha
Ooka, Masato
Xue, Fengtian
Sipes, Nisha S.
Hsieh, Jui-Hua
Ryan, Kristen
Simeonov, Anton
Santillo, Michael F.
Xia, Menghang
author_sort Li, Shuaizhang
collection PubMed
description BACKGROUND: Inhibition of acetylcholinesterase (AChE), a biomarker of organophosphorous and carbamate exposure in environmental and occupational human health, has been commonly used to identify potential safety liabilities. So far, many environmental chemicals, including drug candidates, food additives, and industrial chemicals, have not been thoroughly evaluated for their inhibitory effects on AChE activity. AChE inhibitors can have therapeutic applications (e.g., tacrine and donepezil) or neurotoxic consequences (e.g., insecticides and nerve agents). OBJECTIVES: The objective of the current study was to identify environmental chemicals that inhibit AChE activity using in vitro and in silico models. METHODS: To identify AChE inhibitors rapidly and efficiently, we have screened the Toxicology in the 21st Century (Tox21) 10K compound library in a quantitative high-throughput screening (qHTS) platform by using the homogenous cell-based AChE inhibition assay and enzyme-based AChE inhibition assays (with or without microsomes). AChE inhibitors identified from the primary screening were further tested in monolayer or spheroid formed by SH-SY5Y and neural stem cell models. The inhibition and binding modes of these identified compounds were studied with time-dependent enzyme-based AChE inhibition assay and molecular docking, respectively. RESULTS: A group of known AChE inhibitors, such as donepezil, ambenonium dichloride, and tacrine hydrochloride, as well as many previously unreported AChE inhibitors, such as chelerythrine chloride and cilostazol, were identified in this study. Many of these compounds, such as pyrazophos, phosalone, and triazophos, needed metabolic activation. This study identified both reversible (e.g., donepezil and tacrine) and irreversible inhibitors (e.g., chlorpyrifos and bromophos-ethyl). Molecular docking analyses were performed to explain the relative inhibitory potency of selected compounds. CONCLUSIONS: Our tiered qHTS approach allowed us to generate a robust and reliable data set to evaluate large sets of environmental compounds for their AChE inhibitory activity. https://doi.org/10.1289/EHP6993
format Online
Article
Text
id pubmed-8041433
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Environmental Health Perspectives
record_format MEDLINE/PubMed
spelling pubmed-80414332021-04-13 Profiling the Tox21 Chemical Collection for Acetylcholinesterase Inhibition Li, Shuaizhang Zhao, Jinghua Huang, Ruili Travers, Jameson Klumpp-Thomas, Carleen Yu, Wenbo MacKerell, Alexander D. Sakamuru, Srilatha Ooka, Masato Xue, Fengtian Sipes, Nisha S. Hsieh, Jui-Hua Ryan, Kristen Simeonov, Anton Santillo, Michael F. Xia, Menghang Environ Health Perspect Research BACKGROUND: Inhibition of acetylcholinesterase (AChE), a biomarker of organophosphorous and carbamate exposure in environmental and occupational human health, has been commonly used to identify potential safety liabilities. So far, many environmental chemicals, including drug candidates, food additives, and industrial chemicals, have not been thoroughly evaluated for their inhibitory effects on AChE activity. AChE inhibitors can have therapeutic applications (e.g., tacrine and donepezil) or neurotoxic consequences (e.g., insecticides and nerve agents). OBJECTIVES: The objective of the current study was to identify environmental chemicals that inhibit AChE activity using in vitro and in silico models. METHODS: To identify AChE inhibitors rapidly and efficiently, we have screened the Toxicology in the 21st Century (Tox21) 10K compound library in a quantitative high-throughput screening (qHTS) platform by using the homogenous cell-based AChE inhibition assay and enzyme-based AChE inhibition assays (with or without microsomes). AChE inhibitors identified from the primary screening were further tested in monolayer or spheroid formed by SH-SY5Y and neural stem cell models. The inhibition and binding modes of these identified compounds were studied with time-dependent enzyme-based AChE inhibition assay and molecular docking, respectively. RESULTS: A group of known AChE inhibitors, such as donepezil, ambenonium dichloride, and tacrine hydrochloride, as well as many previously unreported AChE inhibitors, such as chelerythrine chloride and cilostazol, were identified in this study. Many of these compounds, such as pyrazophos, phosalone, and triazophos, needed metabolic activation. This study identified both reversible (e.g., donepezil and tacrine) and irreversible inhibitors (e.g., chlorpyrifos and bromophos-ethyl). Molecular docking analyses were performed to explain the relative inhibitory potency of selected compounds. CONCLUSIONS: Our tiered qHTS approach allowed us to generate a robust and reliable data set to evaluate large sets of environmental compounds for their AChE inhibitory activity. https://doi.org/10.1289/EHP6993 Environmental Health Perspectives 2021-04-12 /pmc/articles/PMC8041433/ /pubmed/33844597 http://dx.doi.org/10.1289/EHP6993 Text en https://ehp.niehs.nih.gov/about-ehp/licenseEHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted.
spellingShingle Research
Li, Shuaizhang
Zhao, Jinghua
Huang, Ruili
Travers, Jameson
Klumpp-Thomas, Carleen
Yu, Wenbo
MacKerell, Alexander D.
Sakamuru, Srilatha
Ooka, Masato
Xue, Fengtian
Sipes, Nisha S.
Hsieh, Jui-Hua
Ryan, Kristen
Simeonov, Anton
Santillo, Michael F.
Xia, Menghang
Profiling the Tox21 Chemical Collection for Acetylcholinesterase Inhibition
title Profiling the Tox21 Chemical Collection for Acetylcholinesterase Inhibition
title_full Profiling the Tox21 Chemical Collection for Acetylcholinesterase Inhibition
title_fullStr Profiling the Tox21 Chemical Collection for Acetylcholinesterase Inhibition
title_full_unstemmed Profiling the Tox21 Chemical Collection for Acetylcholinesterase Inhibition
title_short Profiling the Tox21 Chemical Collection for Acetylcholinesterase Inhibition
title_sort profiling the tox21 chemical collection for acetylcholinesterase inhibition
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041433/
https://www.ncbi.nlm.nih.gov/pubmed/33844597
http://dx.doi.org/10.1289/EHP6993
work_keys_str_mv AT lishuaizhang profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT zhaojinghua profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT huangruili profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT traversjameson profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT klumppthomascarleen profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT yuwenbo profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT mackerellalexanderd profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT sakamurusrilatha profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT ookamasato profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT xuefengtian profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT sipesnishas profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT hsiehjuihua profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT ryankristen profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT simeonovanton profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT santillomichaelf profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition
AT xiamenghang profilingthetox21chemicalcollectionforacetylcholinesteraseinhibition